Basic Information
Clopidogrel Krka d.d. (previously Zopya)
Regulatory Information
EMEA/H/C/001137
Authorised
September 20, 2009
16
February 29, 2024
Company Information
Norpharm Regulatory Services Ltd
norpharm regulatory services ltd
Drug Classification
Generic Medicine
Active Substances Detail
clopidogrel (as hydrochloride)
EMA Resources
Detailed Information
Overview Summary
This is a summary of the European public assessment report (EPAR) for Clopidogrel Krka d.d. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Clopidogrel Krka d.d.